NCT03900624View on ClinicalTrials.gov

Ideal Steroids for Asthma Treatment in the PICU

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

April 21, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

May 15, 2022

Conditions
Asthma Childhood
Interventions
DRUG

Dexamethasone

Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus

Trial Locations (1)

33701

Johns Hopkins All Children's Hospital, St. Petersburg

All Listed Sponsors
lead

Johns Hopkins All Children's Hospital

OTHER

NCT03900624 - Ideal Steroids for Asthma Treatment in the PICU | Biotech Hunter | Biotech Hunter